http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39acbc27a3979697ecac7e5424f79406
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Vries G.E. de Vries de Vries |
| name | Elisabeth GE de Vries Elisabeth G.E de Vries Elisabeth G.E. de Vries |
| given-name | Elisabeth Elisabeth G.E. de Elisabeth GE Elisabeth G.E Elisabeth G.E. |
| organization-name | Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands Authors' Affiliations: Departments of 1Medical Oncology, 2Hospital and Clinical Pharmacy, 3Nuclear Medicine and Molecular Imaging, and 4Pathology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands; 5Academic Department of Radiation Oncology, The Christie Hospital, Manchester, United Kingdom; and 6Department of Surgery, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands Department of Medical Oncology University of Groningen, University Medical Centre Groningen The Netherlands From the Departments of Medical Oncology, Hospital Pharmacy, Nuclear Medicine and Cardiology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands. 1Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands. Department of Internal Medicine, Division of Medical Oncology University Hospital Groningen P.O. Box 30.001, 9700 Groningen The Netherlands 2Medical Oncology, and Authors' Affiliation: Department of Medical Oncology, University of Groningen and University Medical Center, Groningen, the Netherlands Authors' Affiliation: Department of Medical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands From the Departments of Gastroenterology, Clinical Genetics, Pathology, Obstetrics and Gynecology, and Medical Oncology, University Hospital Groningen, Groningen; and Departments of Human Genetics and Pathology, University Medical Center Nijmegen, Nijmegen, the Netherlands. University Medical Center Groningen, University of Groningen, Groningen, the Netherlands 4Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Department of Cardiology University Hospital Groningen P.O. Box 30001, Thorax centre, Hanzeplein 1 9700 RB Groningen The Netherlands Authors' Affiliation: Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands Department of Medical Oncology University Medical Center Groningen University of Groningen Groningen The Netherlands Authors' Affiliations: Department of 1Gynecologic Oncology, 2Pathology, 3Medical Oncology, and 4Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 5Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands; and 6Netherlands Bioinformatics Centre (NBIC), Nijmegen, The Netherlands 1Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Donald A. Berry, Naoto T. Ueno, Marcella M. Johnson, Xiudong Lei, Jean Caputo, Gabriel N. Hortobagyi, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Sjoerd Rodenhuis, the Netherlands Cancer Institute, Amsterdam, the Netherlands; William P. Peters, Regional Consultants in Hematology Oncology, Amelia Island, FL; Robert C. Leonard, Charing Cross Hospital, London, United Kingdom; William E. Barlow, Southwest Oncology Group Statistical Center, Seattle, WA; Martin S. Tallman, Memorial Sloan... From the Comprehensive Cancer Center North-Netherlands; Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen; Comprehensive Cancer Center; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam; Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen; Comprehensive Cancer Center South, Eindhoven; and the Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX; Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Rodney Pommier, Oregon Health & Science University, Portland, OR; Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany; Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven,... From the Departments of Medical Oncology (H.-B.F., E.G.E.d.V.), Nuclear Medicine and Molecular Imaging (A.H.B.), and Endocrinology (T.P.L.), University Medical Center Groningen, Groningen, the Netherlands. Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, The Netherlands From the Departments of Gynecological Oncology, Pathology, Radiotherapy, Medical Oncology, and Epidemiology and Statistics, University Hospital Groningen; Department of Gynecological Oncology, University Hospital Amsterdam, Amsterdam; and Department of Obstetrics and Gynecology, Meander Medical Centre, Amersfoort, The Netherlands. Department of Medical Oncology, University Hospital Groningen, The Netherlands From the Departments of Medical Oncology, Nuclear Medicine and Molecular Imaging, Radiology, and Hospital and Clinical Pharmacy, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands University Medical Center Groningen, Department of Medical Oncology, University of Groningen, Groningen, the Netherlands 2University Medical Center Groningen, University of Groningen, the Netherlands. University of Groningen, Groningen, the Netherlands 1Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Medical Oncology, University Hospital Groningen, Groningen, The Netherlands From the Department of Medical Oncology, Erasmus MC, University Medical Center, Rotterdam; Department of Medical Oncology and Pulmonology, University Hospital Groningen, Groningen, the Netherlands; and Abbott Laboratories, Chicago, IL. 2University Medical Center Groningen, Groningen, the Netherlands; and Cornelia A.J. Brouwer, Aleida Postma, H. Louise H. Hooimeijer, Andries J. Smit, Judith M. Vonk, Arie M. van Roon, Maarten P. van den Berg, Wil V. Dolsma, Joop D. Lefrandt, Margreet T.E. Bink-Boelkens, Nynke Zwart, Wim J.E. Tissing, Elisabeth G.E. de Vries, and Jourik A. Gietema, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. 5Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands Medical Oncology Authors' Affiliations: Departments of 1Medical Oncology, 2Gynecological Oncology, 3Hospital and Clinical Pharmacy, and 4Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands From the Departments of Nuclear Medicine and Molecular Imaging, Medical Oncology, Pathology and Laboratory Medicine, and Endocrinology, University Medical Center Groningen, University of Groningen; Department of Radiology, Martini Hospital Groningen, the Netherlands Authors' Affiliations: Departments of 1Medical Oncology, 2Nuclear Medicine and Molecular Imaging, and 3Hospital and Clinical Pharmacy, University of Groningen and University Medical Center Groningen, Groningen; and 4Optical Sciences Group, MESA+ Institute for Nanotechnology, University of Twente, Enschede, the Netherlands Department of Medical Oncology University of Groningen and University Medical Center Groningen The Netherlands Department of Medical Oncology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands Department of Medical Oncology, University of Groningen and University Medical, Center Groningen, Groningen, The Netherlands University Medical Center Groningen, University of Groningen, the Netherlands Department of Medical Oncology, University Medical Center, University of Groningen, Groningen, The Netherlands Authors' Affiliations: 1Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; 2Department of Medical Oncology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; and 3Human Genome Sciences, Inc., Rockville, Maryland 1Medical Oncology, Departments of Authors' Affiliations: Departments of 1Medical Oncology, Laetitia E. Lamberts, Anton G.T. Terwisscha van Scheltinga, Marjolijn N. Lub-de Hooge, Carolien P. Schröder, Jourik A. Gietema, Adrienne H. Brouwers, and Elisabeth G.E. de Vries, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; and Simon P. Williams, Genentech, South San Francisco, CA. Department of Medical Oncology, Cancer Research Center Groningen University of Groningen, University Medical Center Groningen Groningen The Netherlands From the University Medical Center Groningen and University of Groningen, Groningen; The Netherlands Cancer Institute, Amsterdam; Erasmus Medical Center/Daniel den Hoed Cancer Center, Rotterdam; University Medical Center Nijmegen, Nijmegen; University Medical Center Utrecht, Utrecht; Medical Spectrum Twente, Enschede; Leiden University Medical Center, Leiden; and University Hospital, Maastricht, the Netherlands From the Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital, Rotterdam, and Department of Medical Oncology, University Hospital Groningen, Groningen, the Netherlands; and Gilead Sciences Inc, Boulder, CO. 1Department of Medical Oncology, University of Groningen, University Medical Center Groningen, the Netherlands. Departments of Medical Oncology, 9700 RB Groningen, The Netherlands From the University Medical Center Groningen, University of Groningen, Groningen, The Netherlands Cancer Institute; Amsterdam; Erasmus Medical Center/Daniel den Hoed Cancer Center, Rotterdam, University Medical Center Nijmegen St. Radboud, Nijmegen; Free University Hospital, Amsterdam; Medical Spectrum, Enschede, Leiden University Medical Center; University Medical Center, Utrecht; University Hospital, Maastricht, The Netherlands Department of Gynecological Oncology, Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands |
Incoming Links
Total number of triples: 343.